Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-20 11:40 am Purchase | 2022-12-02 | 13D | CASI Pharmaceuticals, Inc. CASI | SPARKLE BYTE LTD | 1,019,852 7.600% | 0![]() (+0.00%) | Filing History |
2023-02-21 07:33 am Purchase | 2022-06-01 | 13D | CASI Pharmaceuticals, Inc. CASI | Ho Chi Sing | 1,053,638 7.700% | 68,801![]() (+6.99%) | Filing History |
2023-02-09 10:48 am Sale | 2023-01-31 | 13G | CASI Pharmaceuticals, Inc. CASI | FEDERATED HERMES INC. FHI | 661,070 4.860% | -239,581![]() (-26.60%) | Filing History |
2023-02-01 10:39 am Purchase | 2022-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | FEDERATED HERMES INC. FHI | 900,651 6.620% | 900,651![]() (New Position) | Filing History |
2022-06-21 4:26 pm Purchase | 2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,761,349 18.950% | 2,761,349![]() (New Position) | Filing History |
2022-02-14 1:55 pm Sale | 2021-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | Consonance Capital Management LP | 0 0.000% | -757,643![]() (Position Closed) | Filing History |
2022-02-14 1:21 pm Purchase | 2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 10,150,000 7.260% | 3,150,000![]() (+45.00%) | Filing History |
2021-11-23 5:15 pm Purchase | 2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,598,199 17.470% | 438,000![]() (+20.28%) | Filing History |
2021-04-30 4:11 pm Sale | 2021-04-26 | 13D | CASI Pharmaceuticals, Inc. CASI | SPECTRUM PHARMACEUTICALS INC SPPI | 688,696 4.900% | -234,736![]() (-25.42%) | Filing History |
2021-02-17 3:09 pm Purchase | 2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | Consonance Capital Management LP | 757,643 6.110% | 151,793![]() (+25.05%) | Filing History |
2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI | Consonance Capital Management LP | 605,851 9.990% | 605,851![]() (New Position) | Filing History |
2021-02-12 3:01 pm Purchase | 2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 7,000,000 5.650% | 7,000,000![]() (New Position) | Filing History |
2021-02-03 4:01 pm Purchase | 2021-02-01 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,160,199 16.260% | 384,747![]() (+21.67%) | Filing History |
2020-08-18 4:04 pm Purchase | 2020-08-18 | 13D | CASI Pharmaceuticals, Inc. CASI | SPECTRUM PHARMACEUTICALS INC SPPI | 923,432 7.500% | 923,432![]() (New Position) | Filing History |
2020-07-29 5:16 pm Purchase | 2020-07-24 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 1,775,452 13.780% | 520,900![]() (+41.52%) | Filing History |
2020-03-24 4:01 pm Purchase | 2020-03-18 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 1,254,553 12.070% | 323,957![]() (+34.81%) | Filing History |
2020-02-19 4:05 pm Purchase | 2019-12-30 | 13G | CASI Pharmaceuticals, Inc. CASI | Wealth Strategy Holding Ltd | 1,068,463 10.910% | 55,970![]() (+5.53%) | Filing History |